Literature DB >> 29514034

Primary Sjögren's Syndrome.

Xavier Mariette1, Lindsey A Criswell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29514034     DOI： 10.1056/NEJMcp1702514

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  131 in total

1.  Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren's syndrome (pSS) via suppressing NF-κb signaling pathway.

Authors:  Hong Zhu; Jian Zheng; Yan Zhou; Tong Wu; Tiantian Zhu
Journal:  Mol Cell Biochem       Date:  2021-01-29       Impact factor: 3.396

Review 2.  The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy.

Authors:  Malika Hale; David J Rawlings; Shaun W Jackson
Journal:  Curr Opin Immunol       Date:  2018-11-01       Impact factor: 7.486

3.  Decrease in alpha-1 antiproteinase antitrypsin is observed in primary Sjogren's syndrome condition.

Authors:  Brij B Singh; Joyce Ohm; Fredice O Quenum Zanbede; Pooja Chauhan; Frans G M Kroese; Arjan Vissink; Julian L Ambrus; Bibhuti B Mishra
Journal:  Autoimmunity       Date:  2020-05-25       Impact factor: 2.815

4.  American Indians Have a Higher Risk of Sjögren's Syndrome and More Disease Activity Than European Americans and African Americans.

Authors:  R Hal Scofield; Rohan Sharma; Nathan Pezant; Jennifer A Kelly; Lida Radfar; David M Lewis; C Erick Kaufman; Sarah Cioli; Judy Harris; Kiely Grundahl; Nelson L Rhodus; Daniel J Wallace; Michael H Weisman; Swamy Venuturupalli; Michael T Brennan; Kristi A Koelsch; Christopher J Lessard; Courtney G Montgomery; Kathy L Sivils; Astrid Rasmussen
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-07-05       Impact factor: 4.794

5.  Clinical and serological characteristics of seronegative primary Sjögren's syndrome: a comparative study.

Authors:  Veli Yazisiz; Bengisu Aslan; Funda Erbasan; İsmail Uçar; Tahir Saygin Öğüt; Mustafa Ender Terzioğlu
Journal:  Clin Rheumatol       Date:  2020-06-05       Impact factor: 2.980

6.  [Investigation of sleep disturbance and related factors in patients with primary Sjögren's syndrome].

Authors:  Y F Wang; Z Fan; Y B Cheng; Y B Jin; Y Huo; J He
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

7.  Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren's Syndrome.

Authors:  Soledad Retamozo; Chiara Baldini; Hendrika Bootsma; Salvatore De Vita; Thomas Dörner; Benjamin A Fisher; Jacques-Eric Gottenberg; Gabriela Hernández-Molina; Agnes Kocher; Belchin Kostov; Aike A Kruize; Thomas Mandl; Wan-Fai Ng; Raphaèle Seror; Yehuda Shoenfeld; Antoni Sisó-Almirall; Athanasios G Tzioufas; Arjan Vissink; Claudio Vitali; Simon J Bowman; Xavier Mariette; Manuel Ramos-Casals; Pilar Brito-Zerón
Journal:  Drugs Aging       Date:  2021-02-23       Impact factor: 3.923

Review 8.  Current and future therapies for primary Sjögren syndrome.

Authors:  Raphaèle Seror; Gaetane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2021-06-29       Impact factor: 20.543

Review 9.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

10.  Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional study.

Authors:  Yuying Zhang; Mengtao Li; Liyun Zhang; Qin Li; Pinting Yang; Xiaodan Kong; Xinwang Duan; Miaojia Zhang; Xiaomei Li; Yongfu Wang; Jian Xu; Yanhong Wang; Evelyn Hsieh; Jiuliang Zhao; Dong Xu; Yan Zhao; Xiaofeng Zeng
Journal:  Clin Rheumatol       Date:  2020-03-07       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.